Page last updated: 2024-11-06

reserpine and Cardiometabolic Syndrome

reserpine has been researched along with Cardiometabolic Syndrome in 3 studies

Reserpine: An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
reserpine : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.

Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.

Research Excerpts

ExcerptRelevanceReference
"Reserpine is as old as the scientific diagnosis of hypertension."8.12Therapeutic potential of reserpine in metabolic syndrome: An evidence based study. ( Paliwal, S; Sharma, S; Verma, K, 2022)
"Reserpine is as old as the scientific diagnosis of hypertension."4.12Therapeutic potential of reserpine in metabolic syndrome: An evidence based study. ( Paliwal, S; Sharma, S; Verma, K, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Verma, K2
Paliwal, S2
Sharma, S2
Singh, UP1
Gahtori, P1

Other Studies

3 other studies available for reserpine and Cardiometabolic Syndrome

ArticleYear
Therapeutic potential of reserpine in metabolic syndrome: An evidence based study.
    Pharmacological research, 2022, Volume: 186

    Topics: Blood Pressure; Epoxide Hydrolases; Humans; Hypertension; Metabolic Syndrome; Reserpine

2022
Therapeutic potential of Reserpine in metabolic syndrome.
    Pharmacological research, 2023, Volume: 190

    Topics: Humans; Metabolic Syndrome; Reserpine

2023
Therapeutic potential of reserpine in metabolic syndrome: An evidence-based study.
    Pharmacological research, 2023, Volume: 190

    Topics: Humans; Metabolic Syndrome; Reserpine

2023